Evidence map›Paper›PMID 42867578›Full record

ArticleNeurotoxicity research2026

Aerobic Interval Training and Hesperidin Attenuate Paclitaxel-Induced Memory Impairment in Rats: Roles of Inflammation and Oxidative Stress.

Mahdieh Hojjat Panah, Hanieh Gholamalizadeh, Vafa Baradaran Rahimi, Roya Askari, Zahra Stiri, Marzieh Sadat Azarniveh, Bahram Sadeghi, Matteo Pusceddu, Vahid Reza Askari

Abstract read
PubMed Publisher
In one paragraph

Article in Neurotoxicity research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mahdieh Hojjat PanahDepartment of Exercise Physiology, Faculty of Exercise Science, Hakim Sabzevari University, Sabzevar, Iran.
Hanieh GholamalizadehPatient Safety Research Center, Clinical Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Vafa Baradaran RahimiPatient Safety Research Center, Clinical Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID http://orcid.org/0000-0003-2320-5095
Roya AskariDepartment of Exercise Physiology, Faculty of Exercise Science, Hakim Sabzevari University, Sabzevar, Iran. askari7581@gmail.com.
Zahra StiriDepartment of Exercise Physiology, Faculty of Exercise Science, Hakim Sabzevari University, Sabzevar, Iran.
Marzieh Sadat AzarnivehDepartment of Exercise Sciences, Faculty of Literature and Humanities, Zabol University, Zabol, Iran.
Bahram SadeghiDepartment of Exercise Physiology, Faculty of Exercise Science, Hakim Sabzevari University, Sabzevar, Iran.
Matteo PuscedduThe Sports Laboratory, University of Cagliari, Sardinia, Italy.
Vahid Reza AskariPatient Safety Research Center, Clinical Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran. vahidrezaaskary@gmail.com.ORCID http://orcid.org/0009-0002-4346-6081

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paclitaxel (PTX) is an effective antineoplastic agent used against various types of cancer. However, its use is limited in many patients due to intolerable side effects, including neurotoxicity. This study examined the effects of aerobic interval training and/or hesperidin (HES) on neuroinflammation and memory impairment caused by PTX in rats. Thirty male Wistar rats were randomly divided into five groups: Sham (SH), PTX, PTX + exercise (EX), PTX + HES, and PTX + EX + HES. To induce PTX toxicity, 2 mg/kg of PTX was injected intraperitoneally into the rats on days 1, 3, 5, 7, and 9. The aerobic exercise program involved five treadmill interval training sessions per week for seven weeks, with each session consisting of 2-minute running intervals. In the first week, the rats completed six repetitions, increasing by one each week until reaching 12 in the final week. Exercise intensity gradually increased from 60% of maximum speed in the first week to 75% in the last week. Between intervals, active rest lasted one minute at 40-45% of maximum speed. HES (100 mg/kg) was administered orally one hour before exercise starting on the tenth day after PTX injection. The Shuttle box and Morris water maze tests assessed changes in avoidance and spatial memory. Animals were finally sacrificed, and hippocampal tissue samples were collected to evaluate inflammatory and oxidative stress markers, including tumor necrosis factor-α (TNF-α), interleukin (IL)-6, IL-10, malondialdehyde (MDA), glutathione (GSH), and brain-derived neurotrophic factor (BDNF). Avoidance and spatial memory significantly improved in the exercise and supplement groups compared to the PTX group (P < 0.05), with the most notable improvement in spatial memory observed in the PTX + EX + HES group. The PTX group showed a significant increase in TNF-α, IL-6, and MDA levels compared to the other groups (p˂0.05 - 0.001). Conversely, IL-10 and BDNF levels were significantly lower in the PTX group compared to other groups (p ˂ 0.05 - 0.001). Our results demonstrate that PTX impairs memory and learning ability; however, aerobic interval training and HES supplementation increase BDNF levels and enhance avoidance and spatial memory. Thus, these treatments may help mitigate chemotherapy side effects. Further research is necessary to determine safe and effective dosages.

Indexed as

Antineoplastic Agents, PhytogenicHesperidinMemory DisordersOxidative StressPaclitaxelPhysical Conditioning, AnimalAnimalsBrain-Derived Neurotrophic FactorHippocampusInflammationMaleRatsRats, WistarAntineoplastic Agents, PhytogenicBrain-Derived Neurotrophic FactorHesperidinPaclitaxelAerobic Interval ExerciseHesperidinMemoryNeuroinflammationPaclitaxel

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.